Akira Tanaka

Papers

Total Citations

H-Index

About

Dr. Akira Tanaka is a leading urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the identification of histopathological predictors of treatment failure. His work centers on the intersection of surgical pathology and radiation oncology, aiming to refine post-prostatectomy management strategies. Dr. Tanaka’s most cited study, "Cribriform Pattern Is a Predictive Factor of PSA Recurrence in Patients Receiving Radiotherapy After Prostatectomy" (2024, 2 citations), represents a significant contribution to the field. This paper demonstrates that the presence of a cribriform pattern in prostate cancer specimens is a robust, independent predictor of biochemical recurrence following salvage radiotherapy—a finding that can directly inform clinical decision-making for high-risk patients. By highlighting this morphological marker, Dr. Tanaka provides clinicians with a practical tool to stratify recurrence risk and tailor adjuvant therapies. Though early in its citation trajectory, this work has already garnered attention for its translational relevance, bridging surgical pathology with radiotherapy planning. Dr. Tanaka’s research continues to shape personalized treatment paradigms, offering hope for more precise, effective management of prostate cancer recurrence.